Abstract:Objective To explore the risk factors affecting benign and malignant pancreatic cystic neoplasm (PCN) and prognosis of patients.Methods The retrospective caseocontrol study was adopted.The clinicopathological data of 182 patients with PCN who were admitted to the First Affiliated Hospital of Harbin Medical University from February 2001 to February 2011 were collected.Of 182 patients,146 with benign tumors (non-invasive type) were confirmed as adenomas,borderline tumor and carcinoma in situ by pathological examination,and 36 with malignant tumors (invasive type) were confirmed as invasive carcinomas.The follow-up using telephone interview was performed to detect the survival of patients and tumor recurrence once every 3 months up to February 20,2016.The survival time was from the postoperative first day to death or end of follow-up.The analysis indicators included (1) risk factors affecting benign and malignant tumors:age,gender,body mass index (BMI),diabetes,cigarette smoking,alcohol drinking,history of pancreatitis,clinical symptoms,tumor location,tumor diameter,number of tumors,vascular involvement,levels of serum CA19-9 and carcinoembryonic antigen (CEA),(2) risk factors affecting prognosis of patients with malignant tumors.The survival curve was drawn by Kaplan-Meier method.The survival rate was done using the Log-rank test,univariate analysis and multivariate analysis were respectively done by the chi-square test or Fisher exact probility and COX regression model.Results (1) Risk factors affecting benign and malignant tumors:results of univariate analysis showed that age,tumor location,levels of serum CA19-9 and CEA were associated with the incidence of malignant PCN (x2=7.79,6.83,20.55,16.55,P ＜0.05).Results of multivariate analysis showed that age≥60 years and serum CEA≥3.4 μg/L were independent risk factors for the preoperative prediction of malignant PCN [OR =8.012,7.429,95％ confidence interval (CI):1.965-32.678,1.403-39.331,P ＜ 0.05].There was colinearity between level of serum CA19-9 and level of serum CEA by association analysis (x2=12.66,P ＜ 0.05).(2) Risk factors affecting prognosis of patients with malignant tumors:36 patients with malignant PCN were followed up for 60months.The 5-year survival rates of patients with preoperative serum CEA ≥3.4 μg/L and ＜ 3.4 μg/L were 27.3％ and 54.5％,respectively,showing a statistically significant difference (x2=5.83,P ＜ 0.05).Results of the COX regression model showed that preoperative serum CEA ≥ 3.4 μg/L was an independent risk factor evaluating the prognosis of patients with malignant PCN (RR =8.499,95％ CI:2.120-34.066,P ＜ 0.05).Conclusion PCN in patients with age ≥ 60 years,serum CA19-9 ≥ 37 U/L and serum CEA ≥ 3.4 μg/L is considered for malignancy and preoperative CEA level can effectively evaluate the prognosis of patients with malignant PCN.

Preoperative diagnosis of the malignancy for pancreatic cystic neoplasms

Diagnostic value of imaging examinations in pancreatic cystic neoplasm

The “extracapsular Cystic” Sign in Pancreatic Serous Cystic Neoplasms: A Clinicopathologic Study of 177 Patients with Cystic Pancreatic Lesions

Pancreatic cystic neoplasms: a review of preoperative diagnosis and management

Cystic Neoplasms of the Pancreas: Differential Diagnosis and Radiology Correlation

Evaluation of Predictive Factors for Malignancy in Cystic Neoplasms of Pancreas

AB086. P058. Current Status of Pancreatic Cystic Neoplasm: Diagnosis and Treatment a Multi-Institution Retrospective Study in China

Diagnosis and treatment of pancreatic cystic neoplasms:a report of 222 cases

A novel distinguishing system for the diagnosis of malignant pancreatic cystic neoplasm.

Current dilemmas and solutions in the management of pancreatic cystic neoplasms

Pancreatic cystic neoplasms: current and future approaches to identify patients at risk

Diagnosis and treatment of pancrean cystic neoplasms:hot and difficult problems

Preoperative differentiation of pancreatic cystic neoplasm subtypes on computed tomography radiomics

The Way We Are Using to Improve the Preoperative Identification of Pancreatic Cystic Neoplasms: 213 Cases in A Single Chinese Pancreatic Surgery Center.

A Series of 64 Cases of Pancreatic Cystic Neoplasia from an Institutional Study of China

Computer-Aided Diagnosis of Pancreas Serous Cystic Neoplasms: A Radiomics Method on Preoperative MDCT Images.

Clinicopathologic Analysis of 92 Cases of Pancreatic Cystic Neoplasm

The differential diagnosis of pancreatic cystic neoplasms with conventional ultrasound and contrast-enhanced ultrasound

Validation of Sendai and Fukuoka Consensus Guidelines in Predicting Malignancy in Patients with Preoperatively Diagnosed Mucinous Pancreatic Cystic Neoplasms.

Risk Factors Analysis of Benign and Malignant Pancreatic Cystic Neoplasm and Prognosis

Reassessment of EUS Features in Preoperative Diagnosis of Pancreatic Serous Cystic Neoplasm: Lessons to Avoid Misdiagnosis.